说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 膀胱尿路上皮癌
1)  Bladder urothelial carcinoma
膀胱尿路上皮癌
1.
Objective To study the thymidine phosphorylase (TP) expression in the bladder urothelial carcinoma (BUC) and its correlation with tumor microvessel density (MVD).
目的研究胸苷磷酸化酶(TP)在膀胱尿路上皮癌(BUC)中的表达,探讨TP与癌组织血管生成的关系。
2.
Objective The purpose of this paper is to investigate the fluorescence in situ hybridization (Fluorescence in situ Hybridization Technique, FISH) in the diagnosis and monitoring recurrence of bladder urothelial carcinoma in the feasibility and effectiveness.
目的:探讨荧光原位杂交技术(Fluorescence in situ Hybridization Technique, FISH)在诊断膀胱尿路上皮癌和监测术后复发中的可行性及有效性。
3.
Objective To investigate the expressions and clinical significance of the tropomyosin-5 (TM5) in the bladder urothelial carcinoma (BUC) to probe into its correlation with tumor.
目的研究原肌球蛋白5(TM5)在膀胱尿路上皮癌(BUC)中的表达,探讨TM5与膀胱癌生物学行为之间的关系。
2)  urothelial carcinoma of bladder
膀胱尿路上皮癌
1.
Expression of EZH2 gene in urothelial carcinoma of bladder and its clinical value;
EZH2基因在膀胱尿路上皮癌中的表达及临床意义
3)  uroepithelium cell carcinoma of bladder
膀胱尿路上皮细胞癌
1.
Objective To study the expression of HER2 in uroepithelium cell carcinoma of bladder,mucosa in the paracarcinoma and normal mucous of urinary bladder,and to explore its correlation with clinic factors,grade and stage of the bladder carcinoma and evaluate whether HER2 can serve as marker to decide the biological behavior of bladder carcinoma.
目的检测HER2在膀胱尿路上皮细胞癌、癌旁黏膜、正常膀胱黏膜组织中的表达,探讨HER2表达与膀胱尿路上皮细胞癌临床特征、病理分级、临床分期间的关系,评价它是否可以作为判断膀胱尿路上皮细胞癌生物学行为的指标。
4)  bladder urothelial carcinoma
膀胱尿路上皮肿瘤
1.
Objective:To study the expression and significance of hTERT and COX-2 in human bladder urothelial carcinoma(BUC).
目的:探讨人端粒酶逆转录酶基因(hTERT)、环氧合酶-2基因(COX-2)在膀胱尿路上皮肿瘤(BUC)中的表达及其与临床病理特征之间的关系。
5)  Nonurothelial bladder cancer
膀胱非尿路上皮性恶性肿瘤
1.
Objective:Nonurothelial bladder cancer frequently presents a diagnostic and therapeutic challenge.
目的:探讨膀胱非尿路上皮性恶性肿瘤的治疗方法和预后。
6)  urothelial cancer
尿路上皮癌
1.
Expression of KAI1 in urothelial cancer tissues and its relationship with invasion and metastasis of urothelial cancer;
KAI1在尿路上皮癌组织中的表达及其与浸润转移的关系
2.
To evaluate the clinical value of NMP22 for the diagnosis of urothelial cancer.
评估尿核基质蛋白 2 2 (NMP2 2 )作为尿路上皮癌肿瘤标记物的临床诊断价值。
补充资料:非上皮性膀胱肿瘤


非上皮性膀胱肿瘤
35%

发生于膀胱间叶组织的肿瘤。主要来源于肌肉、血管、淋巴、神经等组织。其可分恶性、良性两大类,其中膀胱横纹肌肉瘤在恶性中发生率最高(35%);而膀胱平滑肌瘤是良性肿瘤中最常见的一种,占30%~50%。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条